Dr. Jonathan Lipton Featured in BCH Magazine

Dr. Jonathan Lipton is pioneering research on the impact of circadian rhythm disruptions on neurodevelopmental disorders, focusing on conditions like Kleefstra syndrome and Alzheimer’s disease. His team investigates how alterations in the EHMT1 gene, crucial for sleep and brain development, contribute to these disorders’ symptoms. Through studying patients’ cells and sleep cycles, they aim to predict developmental regression risks and develop tailored treatments. Their innovative work, supported by the Boston Investment Conference, aspires to establish circadian medicine as a novel and impactful medical field.